Viewing nowGlimet Tablet (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 200300313 · Notified 2003.11.12 · Insurance code 693900230
Improves blood glucose control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It is mainly administered as an adjunct to diet and exercise therapy, but can also be used alone. If blood sugar control is inadequate with oral hypoglycemic agents, it can be administered in combination with insulin. Additionally, when blood sugar control is difficult with sulfonylureas or metformin monotherapy, this medication can be used with metformin to enhance effectiveness. This medication helps improve the ability to control blood sugar.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received drug therapy, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit with doses greater than 4 mg, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the required dose of this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial Dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the medicine previously administered. 4) Dose monitoring Blood glucose and/or urine glucose levels should be measured regularly during treatment with this medicine, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully treated initially during administration of a sulfonylurea. Therefore, monitor patients carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal; start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Adjust the insulin dose periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine and metformin are used in combination, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is coadministered with metformin, and the risk may increase. Appropriate caution is required.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or coma. It should also not be administered to patients who are allergic to this medication or sulfonylureas, and patients with severe liver or kidney impairment should not take it. Women who are pregnant or breastfeeding should avoid using this medication, and use should be avoided in patients undergoing surgery or in severe infection states. Patients with gastrointestinal disorders should be careful as there is a risk of hypoglycemia with this medication. This medication should also not be given to patients with hereditary lactose intolerance. During the first week of starting this medication, the risk of hypoglycemia is high, so careful blood sugar monitoring is necessary. Particularly, elderly patients, those in poor nutritional state, or patients with irregular eating patterns, and individuals who frequently consume alcohol should exercise extra caution. Patients with reduced kidney or liver function, those with other endocrine disorders, and patients taking multiple medications should also be managed carefully. Patients should inform their physician or pharmacist about symptoms and risk factors of hypoglycemia, and dosage adjustments should be made if necessary. This medication can cause hypoglycemic symptoms due to its blood sugar-lowering action, with symptoms including headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and decreased consciousness. In severe cases of hypoglycemia, symptoms similar to a stroke may occur, so immediate treatment is necessary. Transient visual disturbances, gastrointestinal symptoms, liver function abnormalities, decreased blood cell counts, and allergic reactions have also been reported, so if any unusual symptoms occur, immediate consultation with medical personnel is required. To achieve optimal blood sugar control, this medication must be taken regularly, and dietary and exercise regimens should be followed. In case of hypoglycemia, consuming sugar or sugary beverages can quickly alleviate symptoms, so it is advisable to always carry some sugar. Since hypoglycemic symptoms may recur, careful monitoring and management according to the physician's instructions is necessary. When taking other medications together, the effect of this medication may change, so all medications being taken must be reported to the physician or pharmacist. Particularly, care must be taken regarding interactions with medications that affect the enzymes that break down this medication in the liver or have blood sugar-lowering or raising actions. Pregnant or breastfeeding women should avoid using this medication as it may harm the fetus or newborn, and should transition to insulin therapy if necessary. This medication is not used in children under 18 years of age as its safety and effectiveness have not been established. Elderly patients may have reduced kidney function, so careful determination of the dosage of this medication is required. In case of overdose, severe hypoglycemia may occur, and immediate visit to a medical institution for appropriate treatment is essential; measures such as inducing vomiting, gastric lavage, or intravenous glucose administration may be necessary. This medication should be stored out of reach of children and kept in its original container, as transferring to another container poses risks of misuse or degradation of quality.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivational drive, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the epigastric area, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, dysgeusia, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing of the face, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication must be kept in a tightly sealed container to prevent exposure to air or moisture. Maintaining a storage temperature between 1 and 30 degrees Celsius at room temperature is important. This will help preserve the medication's effectiveness and safety.
Domestic: Green rectangular tablet, Export: Dark blue rectangular tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.